Stocks · US
MDGL
XNAS
Madrigal Pharmaceuticals, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B21.78x
P/S8.88x
EPS$-14.07
ROE-62.07%
ROA-26.12%
Dividend yield0.00%
Debt/Equity0.65
Free cash flow$-206M
Returns and 52-week range
1W-2.55%
1M-8.25%
3M-12.19%
6M-3.02%
1Y+12.06%
YTD-16.40%
52W high$615.00
52W low$393.61
From 52W high-19.28%
Company
HeadquartersWest Conshohocken, PA
Employees915
Listed2007-02-06
Websitewww.madrigalpharma.com
SECFilings
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock | $12.3B | 33.52 | 5.99 | +4.97% |
| DaVita Inc. | $11.4B | 13.45 | — | -1.95% |
| Halozyme Therapeutics, Inc. | $12.3B | 29.72 | 85.64 | -0.43% |
| Bio-Techne Corp. | $11.4B | 62.59 | 5.40 | +0.00% |
| 페넘브라 | $12.5B | 77.78 | 8.16 | -1.59% |
| Elanco Animal Health Incorporated Common Stock | $11.2B | — | 1.71 | -8.24% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.